Viyash Scientific Allots 1,13,001 Equity Shares Under ESOP 2020
Viyash Scientific Limited allotted 1,13,001 equity shares under its ESOP 2020 plan. The exercise price was Rs. 86 per share. This increases the company's paid-up capital to Rs. 87,34,61,620.
The allotment of equity shares under an ESOP is a common practice for employee compensation and retention. The increase in share capital is relatively small compared to the total issued capital and is unlikely to have a significant immediate impact on the company's stock price or overall valuation.
The announcement pertains to the routine allotment of equity shares under an employee stock option plan, which is a standard corporate action and does not inherently indicate a positive or negative shift in the company's financial performance or outlook.
Viyash Scientific Limited (formerly known as Sequent Scientific Limited) has announced the allotment of 1,13,001 Equity Shares of Rs. 2 each, fully paid, to eligible employees. These shares were issued at an exercise price of Rs. 86 per equity share, pursuant to the exercise of options granted under the SeQuent ESOP 2020.
The Nomination and Remuneration Committee of the Company approved this allotment via a resolution passed by circulation on February 23, 2026. The newly allotted Equity Shares will rank pari passu in all respects with the existing equity shares of the Company.
As a consequence of this allotment, the issued and paid-up equity share capital of Viyash Scientific Limited has increased from Rs. 87,32,35,618 (comprising 43,66,17,809 Equity Shares of Rs. 2 each) to Rs. 87,34,61,620 (comprising 43,67,30,810 Equity Shares of Rs. 2 each).
What to do with a filing like this
Viyash Scientific Limited filed this with the NSE as a statutory disclosure, categorised under designated person disclosures. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Viyash Scientific Limited. Read the original for the full detail.